In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells-Reference-Cited by-同舟云学术

In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells

Published:1999-12 Issue:4 Volume:98 Page:535-540
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:

Author:

Sun Y.,Möller P.,Berking C.,Schlüpen E.-M.,Volkenandt M.,Schadendorf D.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2567.1999.00902.x/fullpdf

Reference30 articles.

1. Continuing medical education: Current therapy for cutaneous melanoma.;Johnson;J Am Acad Dermatol,1995

2. Spontaneous regression of malignant melanoma: a review of the literature on incidence, clinical features, and possible mechanisms. Conference on spontaneous regression of cancer.;Nathanson;Natl Cancer Inst Monogr,1976

3. Model predicting survival in stage I melanoma based on tumor progression.;Clark;J Natl Cancer Inst,1989

4. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses.;Sensi;Immunol Today,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung Cancers;Molecular Therapy - Methods & Clinical Development;2020-09

2. The relevance of cytokines for development of protective immunity and rational design of vaccines;Cytokine & Growth Factor Reviews;2007-02

3. Regulatory elements of the melanocortin 1 receptor;Peptides;2005-10

4. Effective anti-tumor adoptive immunotherapy: utilization of exogenous IL-2-independent cytotoxic T lymphocyte clones;International Immunology;2002-12-01

5. Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment;International Journal of Cancer;2002-03-07